Denosumab versus zoledronic acid for osteoporosis treatment in patients with primary biliary cholangitis (the DELTA Study): A multicenter, non-inferiority randomized trial.
Arase Y, Okubo T, Arai T, Abe M, Namisaki T, Uojima H, Matsumoto K, Kakisaka K, Setsu T, Mishima Y, Tsuruya K, Hirose S, Deguchi R, Shiraishi K, Atsukawa M, Ikegami T, Honda A, Terai S, Yoshiji H, Komori A, Tanaka A, Kagawa T.
Arase Y, et al. Among authors: tsuruya k.
Hepatol Commun. 2025 Oct 7;9(11):e0827. doi: 10.1097/HC9.0000000000000827. eCollection 2025 Nov 1.
Hepatol Commun. 2025.
PMID: 41056494
Free PMC article.
Clinical Trial.